Secondary analysis of GRADE (724 adults with type 2 diabetes on metformin): glucagon measures were not associated with HbA1c ≥7.0%, whereas a 1-SD rise in C-peptide index was associated with 17% lower risk; no clear drug differences on glucagon.
Secondary analysisn = 724
Kahn et al. Differential Longitudinal Effects of Glucose-Lowering Medications on Glucagon and C-peptide Responses in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)